|
1
|
Global report on diabetes. World Health
Organization; Geneva: 2016
|
|
2
|
Stattin P, Björ O, Ferrari P, Lukanova A,
Lenner P, Lindahl B, Hallmans G and Kaaks R: Prospective study of
hyperglycemia and cancer risk. Diabetes Care. 30:561–567. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Connolly GC, Safadjou S, Chen R, Nduaguba
A, Dunne R, Khorana AA and Hezel AF: Diabetes mellitus is
associated with the presence of metastatic spread at disease
presentation in hepatocellular carcinoma. Cancer Invest.
30:698–702. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li YG, Ji DF, Zhong S, Lin TB and Lv ZQ:
Hypoglycemic effect of deoxynojirimycin-polysaccharide on high fat
diet and streptozotocin-induced diabetic mice via regulation of
hepatic glucose metabolism. Chem Biol Interact. 225:70–79. 2015.
View Article : Google Scholar
|
|
5
|
Jin L, Xue HY, Jin LJ, Li SY and Xu YP:
Antioxidant and pancreas-protective effect of aucubin on rats with
streptozotocin-induced diabetes. Eur J Pharmacol. 582:162–167.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim MJ, Kim DW, Lee BR, Shin MJ, Kim YN,
Eom SA, Park BJ, Cho YS, Han KH, Park J, et al: Transduced
Tat-glyoxalase protein attenuates streptozotocin-induced diabetes
in a mouse model. Biochem Biophys Res Commun. 430:294–300. 2013.
View Article : Google Scholar
|
|
7
|
Koroglu P, Senturk GE, Yucel D, Ozakpinar
OB, Uras F and Arbak S: The effect of exogenous oxytocin on
streptozotocin (STZ)-induced diabetic adult rat testes. Peptides.
63:47–54. 2015. View Article : Google Scholar
|
|
8
|
Montes S, Rivera-Mancia S, Diaz-Ruiz A,
Tristan-Lopez L and Rios C: Copper and copper proteins in
Parkinson's disease. Oxid Med Cell Longev. 2014:1472512014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klomp LW, Lin SJ, Yuan DS, Klausner RD,
Culotta VC and Gitlin JD: Identification and functional expression
of HAH1, a novel human gene involved in copper homeostasis. J Biol
Chem. 272:9221–9226. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu YY, Nagpure BV, Wong PT and Bian JS:
Hydrogen sulfide protects SH-SY5Y neuronal cells against
d-galactose induced cell injury by suppression of advanced
glycation end products formation and oxidative stress. Neurochem
Int. 62:603–609. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cai H and Peng F: Knockdown of copper
chaperone antioxidant-1 by RNA interference inhibits
copper-stimulated proliferation of non-small cell lung carcinoma
cells. Oncol Rep. 30:269–275. 2013.PubMed/NCBI
|
|
12
|
Uauy R, Olivares M and Gonzalez M:
Essentiality of copper in humans. Am J Clin Nutr. 67(Suppl):
952S–959S. 1998.PubMed/NCBI
|
|
13
|
Díez M, Arroyo M, Cerdàn FJ, Muñoz M,
Martin MA and Balibrea JL: Serum and tissue trace metal levels in
lung cancer. Oncology. 46:230–234. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ozumi K, Sudhahar V, Kim HW, Chen GF,
Kohno T, Finney L, Vogt S, McKinney RD, Ushio-Fukai M and Fukai T:
Role of copper transport protein antioxidant 1 in angiotensin
II-induced hypertension: a key regulator of extracellular
superoxide dismutase. Hypertension. 60:476–486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin SJ and Culotta VC: The ATX1 gene of
Saccharomyces cerevisiae encodes a small metal homeostasis factor
that protects cells against reactive oxygen toxicity. Proc Natl
Acad Sci USA. 92:3784–3788. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kelner GS, Lee M, Clark ME, Maciejewski D,
McGrath D, Rabizadeh S, Lyons T, Bredesen D, Jenner P and Maki RA:
The copper transport protein Atox1 promotes neuronal survival. J
Biol Chem. 275:580–584. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Itoh S, Ozumi K, Kim HW, Nakagawa O,
McKinney RD, Folz RJ, Zelko IN, Ushio-Fukai M and Fukai T: Novel
mechanism for regulation of extracellular SOD transcription and
activity by copper: role of antioxidant-1. Free Radic Biol Med.
46:95–104. 2009. View Article : Google Scholar :
|
|
18
|
Dolgova NV, Nokhrin S, Yu CH, George GN
and Dmitriev OY: Copper chaperone Atox1 interacts with the
metal-binding domain of Wilson's disease protein in cisplatin
detoxification. Biochem J. 454:147–156. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang S, Liu H, Amarsingh GV, Cheung CC,
Hogl S, Narayanan U, Zhang L, McHarg S, Xu J, Gong D, et al:
Diabetic cardiomyopathy is associated with defective myocellular
copper regulation and both defects are rectified by divalent copper
chelation. Cardiovasc Diabetol. 13:100–118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wadia JS and Dowdy SF: Protein
transduction technology. Curr Opin Biotechnol. 13:52–56. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dietz GP: Cell-penetrating peptide
technology to deliver chaperones and associated factors in diseases
and basic research. Curr Pharm Biotechnol. 11:167–174. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van den Berg A and Dowdy SF: Protein
transduction domain delivery of therapeutic macromolecules. Curr
Opin Biotechnol. 22:888–893. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kubo E, Fatma N, Akagi Y, Beier DR, Singh
SP and Singh DP: TAT-mediated PRDX6 protein transduction protects
against eye lens epithelial cell death and delays lens opacity. Am
J Physiol Cell Physiol. 294:C842–C855. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kwon HY, Eum WS, Jang HW, Kang JH, Ryu J,
Ryong Lee B, Jin LH, Park J and Choi SY: Transduction of
Cu,Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic
domain into mammalian cells. FEBS Lett. 485:163–167. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Embury J, Klein D, Pileggi A, Ribeiro M,
Jayaraman S, Molano RD, Fraker C, Kenyon N, Ricordi C, Inverardi L
and Pastori RL: Proteins linked to a protein transduction domain
efficiently transduce pancreatic islets. Diabetes. 50:1706–1713.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim DW, Lee SH, Jeong MS, Sohn EJ, Kim MJ,
Jeong HJ, An JJ, Jang SH, Won MH and Hwang IK: Transduced Tat-SAG
fusion protein protects against oxidative stress and brain ischemic
insult. Free Radic Biol Med. 48:969–977. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shin MJ, Kim DW, Lee YP, Ahn EH, Jo HS,
Kim DS, Kwon OS, Kang TC, Cho YJ, Park J, et al: Tat-glyoxalase
protein inhibits against ischemic neuronal cell damage and
ameliorates ischemic injury. Free Radic Biol Med. 67:195–210. 2014.
View Article : Google Scholar
|
|
28
|
Kim HR, Kim DW, Jo HS, Cho SB, Park JH,
Lee CH, Choi YJ, Yeo EJ, Park SY, Kim ST, et al: Tat-biliverdin
reductase A inhibits inflammatory response by regulation of MAPK
and NF-κB pathways in Raw 264.7 cells and edema mouse model. Mol
Immunol. 63:355–366. 2015. View Article : Google Scholar
|
|
29
|
Kim DW, Lee SH, Ku SK, Cho SH, Cho SW,
Yoon GH, Hwang HS, Park J, Eum WS, Kwon OS and Choi SY: Transduced
PEP-1-FK506BP ameliorates corneal injury in Botulinum toxin
A-induced dry eye mouse model. BMB Rep. 46:124–129. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Youn JK, Kim DW, Kim ST, Park SY, Yeo EJ,
Choi YJ, Lee HR, Kim DS, Cho SW, Han KH, et al: PEP-1-HO-1 prevents
MPTP-induced degeneration of dopaminergic neurons in a Parkinson's
disease mouse model. BMB Rep. 47:569–574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kwon DJ, Bae YS, Ju SM, Youn GS, Choi SY
and Park J: Salicortin suppresses lipopolysaccharide-stimulated
inflammatory responses via blockade of NF-κB and JNK activation in
RAW 264.7 macrophages. BMB Rep. 47:318–323. 2014. View Article : Google Scholar :
|
|
33
|
Ninomiya Y, Cui X, Yasuda T, Wang B, Yu D,
Sekine-Suzuki E and Nenoi M: Arsenite induces premature senescence
via p53/p21 pathway as a result of DNA damage in human malignant
glioblastoma cells. BMB Rep. 47:575–580. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Im CN and Seo JS: Overexpression of tumor
necrosis factor receptor-associated protein 1 (TRAP1), leads to
mitochondrial aberrations in mouse fibroblast NIH/3T3 cells. BMB
Rep. 47:280–285. 2014. View Article : Google Scholar :
|
|
35
|
Kim YM, Lee SM and Chung HS: Novel AGLP-1
albumin fusion protein as a long-lasting agent for type 2 diabetes.
BMB Rep. 46:606–610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Melloul D: Role of NF-kappaB in β-cell
death. Biochem Soc Trans. 36:334–339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Szkudelski T: The mechanism of alloxan and
streptozotocin action in B cells of the rat pancreas. Physiol Res.
50:537–546. 2001.
|
|
38
|
Mo L, Yang C, Gu M, Zheng D, Lin L, Wang
X, Lan A, Hu F and Feng J: PI3K/Akt signaling pathway-induced heme
oxygenase-1 upregulation mediates the adaptive cytoprotection of
hydrogen peroxide preconditioning against oxidative injury in PC12
cells. Int J Mol Med. 30:314–320. 2012.PubMed/NCBI
|
|
39
|
Angeloni C, Motori E, Fabbri D, Malaguti
M, Leoncini E, Lorenzini A and Hrelia S: H2O2
preconditioning modulates phase II enzymes through p38 MAPK and
PI3K/Akt activation. Am J Physiol Heart Circ Physiol.
300:H2196–H2205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nishimoto T, Matsumoto A, Kihara T, Akaike
A and Sugimoto H: Protective effect of H2O2
involves against subsequent H2O2-induced
cytotoxicity activation of the PI3K-Akt signaling pathway. Cell Mol
Biol (Noisy-le-grand). 56(Suppl): OL1447–OL1452. 2010.
|
|
41
|
Jiang X, Tang X, Zhang P, Liu G and Guo H:
Cyanidin-3-O-β-glucoside protects primary mouse hepatocytes against
high glucose-induced apoptosis by modulating mitochondrial
dysfunction and the PI3K/Akt pathway. Biochem Pharmacol.
90:135–144. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rakieten N, Rakieten ML and Nadkarni MV:
Studies on the diabetogenic action of streptozotocin (NSC-37917).
Cancer Chemother Rep. 29:91–98. 1963.PubMed/NCBI
|
|
43
|
Junod A, Lambert AE, Stauffacher W and
Renold AE: Diabet-ogenic action of streptozotocin: relationship of
dose to metabolic response. J Clin Invest. 48:2129–2139. 1969.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bonnefont-Rousselot D: The role of
antioxidant micronutrients in the prevention of diabetic
complications. Treat Endocrinol. 3:41–52. 2004. View Article : Google Scholar
|
|
45
|
Samarghandian S, Borji A, Delkhosh MB and
Samini F: Safranal treatment improves hyperglycemia, hyperlipidemia
and oxidative stress in streptozotocin-induced diabetic rats. J
Pharm Pharm Sci. 16:352–362. 2013.PubMed/NCBI
|
|
46
|
Pi J, Zhang Q, Fu J, Woods CG, Hou Y,
Corkey BE, Collins S and Andersen ME: ROS signaling, oxidative
stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl
Pharmacol. 244:77–83. 2010. View Article : Google Scholar :
|
